RaQualia Pharma Inc.

$5.23

$0.28(-5.13%)

RaQualia Pharma Inc.

4579.T

$5.23

$0.28(-5.13%)

RaQualia Pharma Inc.

4579.T

JPX

$5.23

$0.28(-5.13%)

Chart

Upcoming Earnings

Next report date

May 20, 2026

Report period

Q2 2026

EPS Estimate

—

Revenue Estimate

—

Key stats

52-Week Range$5.23

$1.88

$9.17

Market capitalization

$133.00M

Dividend yield (indicated)

0.00%

Price to earnings Ratio (TTM)

78.69

Basic EPS (TTM)

$0.07

Net income (TTM)

$1.71M

Revenue (TTM)

$24.90M

Avg. volume

666.93K

Beta (1Y)

0.83

Employees

Market capitalization

$133.00M

Dividend yield (indicated)

0.00%

Price to earnings Ratio (TTM)

78.69

Basic EPS (TTM)

$0.07

Net income (TTM)

$1.71M

Revenue (TTM)

$24.90M

Avg. volume

666.93K

Beta (1Y)

0.83

Employees

Screener Quick Check

About RaQualia Pharma Inc.

Sector

Healthcare

Industry

Biotechnology

CEO

Masaki Sudo

Website

www.raqualia.co.jp

Headquarters

Meieki Southside Square, Nagoya, 450-0003

IPO Date

2011-07-20

Identifiers

ISINJP3967150008

Description

RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products...

Related Stocks

Techno Medica Co., Ltd.

6678.T

$15.46Mkt Cap: $107.24M

Healthcare

Medical - Devices

ISIN:JP3545110003

CanBas Co., Ltd.

4575.T

$4.89Mkt Cap: $96.41M

Healthcare

Biotechnology

ISIN:JP3244570002

Dividend Overview

This company does not pay dividends

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate